Home
About
Us
Overview
Management
Ethics
Patents
Products
VASCADE
®
Safe
Simple
Guaranteed
Ordering Info
Videos
VASCADE MVP
®
Early Ambulation
Simple
Proven
Ordering Info
Videos
CATALYST
Overview
Easy to Use
Clinical Data
Ordering Info
Videos
LATEST NEWS:
Wall Street Journal Pro – Cardiva Medical Raises $41 Million.
READ MORE
Value to Hospital
Patients
Resources
News
Press Releases
Cardiva Medical Announces First Patients Enrolled in The AMBULATE Same Day Discharge Study Using VASCADE
®
MVP
Cardiva Medical Announces $45 Million Financing Led by EW Healthcare Partners Robert S. White Joins Board of Directors
Cardiva Medical Appoints Jeri Hilleman to the Company’s Board of Directors Company to Present at the 38th Annual J.P. Morgan Healthcare Conference
Cardiva Medical Announces Publication of Data From the AMBULATE Pivotal Study in the Journal of the American College of Cardiology: Clinical Electrophysiology
Cardiva Medical to Present at the Jefferies 2019 Healthcare Conference
Cardiva Medical Announces FDA Approval of the VASCADE MVP Vascular Closure System for Multi-Site Vessel Closure Following Electrophysiology Procedures
Cardiva Medical Announces Positive Results of the AMBULATE Pivotal Study Evaluating the VASCADE MVP System Compared to Manual Compression for Multi-Vessel Closure Following Electrophysiology Procedures
Cardiva Medical to Present New Clinical Data on the VASCADE MVP System for Multi-Vessel Closure Following Electrophysiology Procedures
Cardiva Medical Awarded Internationally Recognized Shingo Bronze Medallion From the Shingo Institute for Operational Excellence
Cardiva Medical Announces Completion of the AMBULATE Pivotal Trial
Cardiva Medical
®
Announces FDA Approval of VASCADE
®
Vascular Closure System for Use in Femoral Vein Closure
Cardiva Medical Brings Total Financing Round to $41 Million; Announces Sponsorship of AMBULATE Trial, First Vascular Closure Trial Targeted at High Growth Electrophysiology Procedures
Cardiva Medical
®
Raises $30 Million
Cardiva Medical, Inc. Announces Appointment of Lisa Garrett, Chief Financial Officer and VP of Human Resources
Cardiva Medical, Inc. Announces Appointment of John Russell, President and Chief Executive Officer
Cardiva Medical, Inc. Completes Series 3 Private Equity Financing and Secures Debt Facility with GE Capital
Cardiva Medical, Inc. Announces Appointment of Randy Hubbell, Chief Commercial Officer
Cardiva Medical, Inc. Announces FDA Approval for VASCADE™ Vascular Closure System
Cardiva Medical, Inc. Announces That It Has Obtained Approval to Apply the European CE Mark to Its VASCADE™ Vascular Closure System (VCS)
Cardiva Medical, Inc. Completes Third Tranche of Series 2 Private Equity Financing
Cardiva Medical Submits Final PMA Module to FDA for VASCADE™ Vascular Closure System
Cardiva Medical, Inc. Announces Completion of Enrollment in the RESPECT Clinical Trial Aimed at Demonstrating the Safety and Efficacy of the VASCADE Vascular Closure System
Cardiva Medical, Inc. Completes First Tranche of Series 2 Private Equity Financing
Cardiva Medical, Inc. Announces Appointment of Charles Maroney, President and Chief Executive Officer
Contact Us
Careers
Site Map
Home
About Us
Overview
Management
Ethics
Patents
Products
VASCADE®
Safe
Simple
Guaranteed
Ordering Info
Videos
VASCADE MVP®
Early Ambulation
Simple
Proven
Ordering Info
Videos
CATALYST
Overview
Easy to Use
Clinical Data
Ordering Info
Videos
Value to Hospital
Patients
Resources
News
Press Releases
Contact Us
Careers
